Open AccessScreening for hypertrophic cardiomyopathy
Author(s) -
Sunayana C Pydah,
Kimberlee Mauck,
Chelsea Shultis,
Jenna Rolfs,
Eric W. Schmidt,
Joyce S. Nicholas
Publication year - 2021
Publication title -
journal of the american academy of physician assistants
Language(s) - Uncategorized
Resource type - Journals
ISSN - 0893-7400
DOI - 10.1097/01.jaa.0000791464.54226.d8
Subject(s) - hypertrophic cardiomyopathy , asymptomatic , medicine , cardiology , cardiomyopathy , sudden cardiac death , athletes , sudden death , heart failure , physical therapy
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and causes changes in the cardiac muscle affecting ventricular, valvular, and cellular functions. Because HCM is an inherited disorder, all age groups are affected; however, it commonly presents in adolescents, especially athletes. Many patients are asymptomatic and undiagnosed, putting them at risk for sudden cardiac death. This article describes screening and management of patients with HCM.